Author:
Bretagne J. F.,Heresbach D.
Subject
Radiology Nuclear Medicine and imaging
Reference133 articles.
1. ACHARYA S.K., DASARATHY S., SAKSENA S., PANDE J.N. — A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy.J. Hepatol., 1993,19, 291–300.
2. AKRIVIADIS E., KORULA J., GUPTA S., YOUNG K., YAMADA S. — Frequent endoscopic variceal sclerotherapy increases risk of complications: Prospective randomized controlled study of two treatment schedules.Dig. Dis. Sci., 1989,34, 1068–74.
3. ALEXANDRINO P.T., ALVES M.M., PINTO CORREIA J. — Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective randomized controlled trial.J. Hepatol., 1988,7, 175–85.
4. AVGERINOS A., ARMONIS A., MANOLAKOPOULOS S., REKOUMIS G., SIGOUROU A., GOUMA P., RAPTIS S. — Endoscopic sclerotherapy (ES) versus endoscopic ligation (EVL) for the prevention of recurrent esophageal variceal haemorrhage in cirrhotics. A prospective study.Gastroenterology, 1994,106, A369.
5. AVGERINOS A., REKOUMIS G., KLONIS C., PAPADIMITRIOU N., GOUMA P., POURNARAS S., RAPTIS S. — Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial.J. Hepatol., 1993,19, 301–11.